Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Long-Term Deferred Tax: 2021-2022

Historic Long-Term Deferred Tax for ADC Therapeutics (ADCT) over the last 2 years, with Dec 2022 value amounting to $37.1 million.

  • ADC Therapeutics' Long-Term Deferred Tax rose 5.36% to $35.4 million in Q3 2023 from the same period last year, while for Sep 2023 it was $35.4 million, marking a year-over-year increase of 5.36%. This contributed to the annual value of $37.1 million for FY2022, which is 42.44% up from last year.
  • Latest data reveals that ADC Therapeutics reported Long-Term Deferred Tax of $37.1 million as of FY2022, which was up 42.44% from $26.0 million recorded in FY2021.
  • In the past 5 years, ADC Therapeutics' Long-Term Deferred Tax ranged from a high of $37.1 million in FY2022 and a low of $26.0 million during FY2021.
  • In the last 2 years, ADC Therapeutics' Long-Term Deferred Tax had a median value of $31.6 million in 2021 and averaged $31.6 million.
  • Data for ADC Therapeutics' Long-Term Deferred Tax shows a peak YoY soared of 42.44% (in 2022) over the last 5 years.
  • ADC Therapeutics' Long-Term Deferred Tax (Yearly) stood at $26.0 million in 2021, then soared by 42.44% to $37.1 million in 2022.